<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF"><gtr:id>C4ED5B1E-E265-4B92-8BF2-EBDB7897E0CF</gtr:id><gtr:name>Centers for Disease Control and Prevention (CDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E071BB88-81E5-4E53-8C18-F9C7564E0C89"><gtr:id>E071BB88-81E5-4E53-8C18-F9C7564E0C89</gtr:id><gtr:firstName>Claire</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Townsend</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501895"><gtr:id>DB3C2ECB-B165-44E1-A2E6-3BE061478868</gtr:id><gtr:title>Pregnancy outcomes in HIV infected women in the United Kingdom</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0501895</gtr:grantReference><gtr:abstractText>Diagnosis of HIV positive women in pregnancy means that they can reduce the risk of infecting their babies to less than 2% with anti-HIV drugs (antiretrovirals). However, these drugs may have unwanted side effects, including premature delivery. 

In the UK and Ireland, all pregnant women are offered HIV testing, and most accept. HIV rates have increased recently to about 2 per 1000 pregnant women. Almost all infected women take antiretroviral therapy in pregnancy.

Information on HIV positive pregnant women is collected routinely through the National Study of HIV in Pregnancy and Childhood. This allows us to explore the association between HIV treatment in pregnancy and issues such as premature delivery, birth defects and mother-to-child transmission of the virus. 

In some, but not all, studies antiretroviral therapy is associated with an increased risk of premature delivery. We want to explore the reasons for these different findings by looking at three studies. We will try to discover if these differences are due to the way the studies are designed and analysed, or other reasons. 

We hope that a clear understanding of HIV treatment and adverse effects in pregnancy will lead to better outcomes in HIV positive women and their children.</gtr:abstractText><gtr:technicalSummary>The prevalence of HIV infection in pregnant women in the United Kingdom (UK) is increasing, and many women are now diagnosed during antenatal care. With the widespread use of antiretroviral therapy (ART) during pregnancy, there have been concerns over the potential for adverse effects, with different findings from European and American studies regarding prematurity risk.

The aim of this project is to evaluate pregnancy outcome in HIV infected women receiving ART in the UK, using national surveillance data. The project will focus on the association between ART and prematurity, congenital abnormalities, mother-to-child transmission and other pregnancy complications. An appropriate pooled analysis on prematurity including data from two other large-scale studies (in Europe and the United States) will be carried out, and results and methodologies of the three studies will be compared. A further aim of this project is to assess the completeness of the UK surveillance scheme, in order to validate its status as a population-based study. This exercise will be based on internal comparisons, but will also rely on antenatal detection data collected by the Health Protection Agency. Finally, models will be developed to predict the future burden on the health services from adverse outcomes related to ART. 

This project is based on the National Study of HIV in Pregnancy and Childhood (NSHPC), the ongoing national surveillance system. HIV infected women and children in the UK and Ireland, and children born to infected women are reported to the NSHPC through complementary schemes. Information is collected on maternal demographics, ART, pregnancy outcome and infant?s infection status. This project will also incorporate data from the European Collaborative Study and the Pediatric Spectrum of Diseases Study in the USA for a pooled analysis with the NSHPC data. 

Information on over 6000 pregnancies has been collected through the NSHPC since the late 1980s, with over 1000 new pgnancies now added annually. This unique dataset is not fully exploited at present, and provides a tremendous opportunity for further research. This fellowship will allow important additional analyses and will enable a full assessment of the comprehensiveness of the surveillance, an exercise which has not previously been performed. Results of these analyses will inform national guidelines for the management of HIV infected women, and will help midwives and obstetricians provide better quality care for infected women.</gtr:technicalSummary><gtr:fund><gtr:end>2009-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>140295</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Child Health</gtr:department><gtr:description>Pooled analysis of ART and preterm delivery</gtr:description><gtr:id>0B4EA485-8AAC-447E-8ECC-E46680458AA4</gtr:id><gtr:impact>Publication: 20716250, which received media attention from Reuters health. Also posters and oral presentations at international HIV conferences.</gtr:impact><gtr:outcomeId>EE5A6ECEBA1-2</gtr:outcomeId><gtr:partnerContribution>Provision of data for the Pediatric Spectrum of HIV Disease project, co-authoring of paper for publication.Provision of data from the European Collaborative Study of HIV-infected women and children, co-authoring of paper for publication.</gtr:partnerContribution><gtr:piContribution>Analysis of data, drafting of paper for publication, presentation of research at conferences.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Epidemiology for Child Health</gtr:department><gtr:description>MRC Centre of Epidemiology for Child Health</gtr:description><gtr:id>7C512057-1A67-4DE9-A907-1624DE444BBF</gtr:id><gtr:impact>All outputs from this grant between 2007 and 2009 were influenced in some way by this collaboration.</gtr:impact><gtr:outcomeId>iK4xqVhtLxh-1</gtr:outcomeId><gtr:partnerContribution>? Critical mass of epidemiological and statistical expertise applied to children's health.
? 'Epilab' computing facilities, an advanced computing environment and data management service - includes core data storage and backup provision, a virtual desktop and backend-server infrastructure, as well as tools, training and assistance with data transfer, metadata management, data collection. 
? Statistical support: several statisticians within the Centre provide statistical support for ongoing projects. 
? Excellent training and early career development support with opportunities to access supervision and supervisory experience.
? Expertise in the use of evidence for policy and practice and in the development of study designs aimed to maximise impact of research findings for policy and practice</gtr:partnerContribution><gtr:piContribution>Participation in Centre scientific and academic seminars, workshops, symposia and masterclasses and multi-disciplinary team working.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Study of HIV in Pregnancy and Childhood</gtr:department><gtr:description>NSHPC collaboration</gtr:description><gtr:id>F1EB2223-842D-4C00-AB7D-3A59495B5379</gtr:id><gtr:impact>All outputs produced from this MRC grant were beneficial to the NSHPC, since they raised awareness of the surveillance scheme and comprised an important part of the overall dissemination activities of the NSHPC.</gtr:impact><gtr:outcomeId>8451A6BD949-1</gtr:outcomeId><gtr:partnerContribution>The National Study of HIV in Pregnancy and Childhood (NSHPC) is an ongoing surveillance study based at the Institute of Child Health, University College London. This study provided the basis for all my research: all the data I analysed and presented was collected through this study between 1990 and 2008. My supervisor was the principal investigator of this study and provided guidance and input into my own research, and other researchers in the team also contributed to the interpretation of my results and were co-authors on publications.</gtr:partnerContribution><gtr:piContribution>I provided input into data collection methods, interpretation of data, development of new research questions, and dissemination of findings through quarterly newsletter and other routes.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centers for Disease Control and Prevention (CDC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Pooled analysis of ART and preterm delivery</gtr:description><gtr:id>7A7ACE4B-A65D-422D-B558-D022C937B367</gtr:id><gtr:impact>Publication: 20716250, which received media attention from Reuters health. Also posters and oral presentations at international HIV conferences.</gtr:impact><gtr:outcomeId>EE5A6ECEBA1-1</gtr:outcomeId><gtr:partnerContribution>Provision of data for the Pediatric Spectrum of HIV Disease project, co-authoring of paper for publication.Provision of data from the European Collaborative Study of HIV-infected women and children, co-authoring of paper for publication.</gtr:partnerContribution><gtr:piContribution>Analysis of data, drafting of paper for publication, presentation of research at conferences.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press release, MTCT paper</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5CA744C7-3D13-4242-8873-4D50427D4105</gtr:id><gtr:impact>Press release associated with publication (pubmed reference: 18453857).

Press coverage on the BBC website, Times Online, the Metro and others.</gtr:impact><gtr:outcomeId>DB5650E6F79</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Response to Reuters enquiry</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>57963F54-7AFB-4731-B7EE-3B54C13A21CB</gtr:id><gtr:impact>Responded to an equiry from a journalist from Reuters Health regarding publication (PMID 20716250)

Article and webcast published online (www.thedoctorschannel.com) - more than 1500 viewings as of 15 Nov 2010.</gtr:impact><gtr:outcomeId>p6Cexsfn8vi</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.thedoctorschannel.com</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Plenary presentation, RCPCH 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DFA7C1C5-7C9A-46CA-9FA1-4DA522816F69</gtr:id><gtr:impact>15 minute plenary presentation entitled 'Very Low Risk of Mother-to-Child Transmission (MTCT) in Women on HAART Who Achieve Viral Suppression: Data from the United Kingdom and Ireland, 2000-2006'. Royal College of Paediatrics and Child Health (RCPCH) 12th Spring Meeting in York, UK.

Invited to give a talk at the British HIV Association Autumn Conference, Children's HIV Association parallel session, on infants born to diagnosed HIV-infected women.</gtr:impact><gtr:outcomeId>7A428EADABF</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation, Screening Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DE20D99A-EC2F-4611-9DEE-BE25ED0BDB14</gtr:id><gtr:impact>15 min presentation at the Health Protection Agency and UK National Screening Committee Infectious Diseases in Pregnancy Screening Programme Development Workshop, attended by 10-15 Antenatal Screening Coordinators from across the country. Topic: &amp;quot;The National Study of HIV in Pregnancy and Childhood - a model of best practice&amp;quot;. 31 October 2007, London, Royal College of Obstetricians and Gynaecologists.

Enhanced awareness among antenatal screening coordinators of the role of the HIV surveillance scheme in relation to other systems for monitoring infections in pregnancy.</gtr:impact><gtr:outcomeId>FAD7DBC7066</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NSHPC Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7BFAC9BB-34A3-4EA2-A5A3-F95135985513</gtr:id><gtr:impact>Contributions to most issues of the National Study of HIV in Pregnancy and Childhood's quarterly newsletter. Circulated to all 250 or so clinicians, midwives and other health professionals who report to the surveillance scheme, as well as to HIV charity organisations such as Positive Nation, Positively Women and others, and the Health Protection Agency. Newsletters are also available on the study's website: www.nshpc.ucl.ac.uk

Raised awareness among health professionals of the research findings that result from the information they report.</gtr:impact><gtr:outcomeId>C34B18311D3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Posters, International AIDS Conference 2008 &amp; 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>56CEB1AA-36AF-4417-8AA2-0BF70D3C8B33</gtr:id><gtr:impact>Conference attended by 20,000 delegates from a wide range of disciplines, including medicine, social and basic science, policy and advocacy. 

- 2008: poster entitled 'Differences in the association between HAART in pregnancy and premature delivery: a comparison of three studies in the United States and Europe.' XVII International AIDS conference. Mexico City, 3-8 August 2008. Abstract MOPE0498. 

- 2010: poster entitled 'Insufficient antenatal antiretroviral therapy: missed opportunities for PMTCT in Europe' XVIII International AIDS Conference, Vienna, Austria, 18-23 July 2010. Abstract CDC0562.

No specific measurable impacts.</gtr:impact><gtr:outcomeId>kSMin83Kd8u</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster, IAS 2009</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EB8D2899-07C3-4DCE-B171-E2FD9842F56D</gtr:id><gtr:impact>Presented poster entitled 'Exploring heterogeneity in the association between HAART and prematurity in three observational studies' at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, South Africa, 19-22 July 2009. Abstract WEPEB263. The conference had &amp;gt;5800 paticipants from a range of fields.

3 minute interview by thebodypro.com about the importance of these findings in relation to other studies.</gtr:impact><gtr:outcomeId>21944BEF43A</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral Presentation, HPA 2007 &amp; 2009</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C39BB67C-CB78-4655-AB88-134C2B1C12AA</gtr:id><gtr:impact>15 min oral presentation (2007) &amp;amp; poster (2009) at the Health Protection Agency's annual conferences, Warwick University. Conference attended by 1300 participants &amp;quot;working across the breadth of health protection, from public health services and hospitals, industry, environmental health, emergency planning, laboratories, research institutions and Government agencies and departments.&amp;quot;

Raised awareness of research outputs among public health professionals and colleagues at the Health Protection Agency and Department of Health.</gtr:impact><gtr:outcomeId>4AB277EDB86</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation, ECS Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BAD0242A-E4A3-4ADC-8979-91A10CA9EFB1</gtr:id><gtr:impact>Presentation of research findings at the European Collaborative Study Meeting, &amp;quot;Antiretroviral therapy in pregnancy and preterm delivery - a pooled analysis&amp;quot;. Monkey Island, UK, 23-24 November 2009. Attended by 15-20 clinicians from several European countries involved in the European Collaborative Study.

Helpful discussion around interpretation of findings.</gtr:impact><gtr:outcomeId>5EB510904E7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Posters, CROI 2007, 2008 &amp; 2009 &amp; 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7176BE1F-FA4D-48C9-9AA0-E0B5174799C8</gtr:id><gtr:impact>Mixed audience of around 5000 clinicians and scientists.

- 2007: Poster entitled 'Trends in mother-to-child transmission of HIV in the UK and Ireland: 1990-2004'. 14th CROI, Los Angeles, 25-28 February 2007. 
- 2008: Poster entitled 'Very Low Risk of Mother-to-Child Transmission (MTCT) in Women on HAART Who Achieve Viral Suppression: Data from the United Kingdom and Ireland, 2000-2006.' 15th CROI, Boston, USA, February 2008. 
- 2009: Poster entitled 'Premature delivery and mother-to-child transmission: risks and benefits of HAART in pregnancy', 16th CROI, Montreal, Canada, 8-11 February 2009. 
- 2013: Poster updating previous work, 'Mother-to-child transmission continues to decline in the UK &amp;amp; Ireland', 20th CROI, Atlanta, USA, 3-6th March 2013.

Received important input from UK and American clinicians into direction of subsequent work on mother-to-child transmission. 

Raised awareness of research findings among clinicians involved in writing the British HIV Association Guidelines for the Management of HIV in Pregnancy. Findings incorporated into 2008 and 2012 Guidelines (see Influence on Policy section).</gtr:impact><gtr:outcomeId>D24C6DB06C0</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.croi2014.org/</gtr:url><gtr:year>2007,2008,2009,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral presentation, RCPCH 2007 &amp; 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>39D47613-FEE7-4F80-9FD3-54FD645C0082</gtr:id><gtr:impact>- 2007: 15 min oral presentation entitled 'Vertically acquired HIV infection in the UK and Ireland in the era of routine antenatal testing (2000-2005)'. Royal College of Paediatrics and Child Health 11th Spring Meeting, York, UK. Allergy, immunity and infection session. 
- 2008: 15 minute oral presentation entitled 'Congenital abnormalities and in utero exposure to antiretroviral therapy in the UK and Ireland'. Royal College of Paediatrics and Child Health 12th Spring Meeting, York, UK. Allergy, infection and immunity session.

Raised awareness among clinicians of the importance of reporting children born to HIV-infected women to the NSHPC.</gtr:impact><gtr:outcomeId>9823D81D477</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oral presentation, Paediatrics Workshop 2009</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F7C14C71-C498-4E8D-81A4-7C37D3BDB121</gtr:id><gtr:impact>Gave an oral presentation entitled 'Prematurity and mother-to-child transmission: risk-benefit analysis of antiretroviral therapy in pregnancy' at the 1st International Workshop on HIV Pediatrics, Cape Town, South Africa, 17-18 July 2009. Audience of around 250 clinicians and researchers.

No specific, measurable impacts.</gtr:impact><gtr:outcomeId>7AA2EE18B56</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CHIVA Monday Evening Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B7D1E98A-E5F2-4F18-ACF8-BE9BB2FC870F</gtr:id><gtr:impact>Gave a 15 min update on the National Study of HIV in Pregnancy and Childhood at the Children's HIV Association Monday evening meeting, 12 November 2007. These are educations meetings for London-based health professionals (paediatricians, clinical nurse specialists, nutritionists etc) with an interest in paediatric HIV. Attendance 30-50 people.

Raised awareness among paediatricians of the importance of reporting children born to HIV-infected women to the national surveillance system, so that robust estimates of mother-to-child transmission can be obtained.</gtr:impact><gtr:outcomeId>78A85ECC48B</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>5955</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Value in People Award</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>F80522DF-0CE4-4E73-8604-9523FC387B1A</gtr:id><gtr:outcomeId>trGwne6LZyM0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>89998</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellchild Research Training Fellowship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>WellChild</gtr:fundingOrg><gtr:id>FA7855A9-30DB-4FCA-BA1F-3C4AD821CDB8</gtr:id><gtr:outcomeId>Dgh81cA9ASX0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>US Pregnancy Guidelines</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:guidelineTitle>Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States</gtr:guidelineTitle><gtr:id>F1F807FB-F694-42E2-A030-6C6445A9F9C9</gtr:id><gtr:outcomeId>En3jUmLzFBi</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Swedish Guidelines</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:guidelineTitle>Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010</gtr:guidelineTitle><gtr:id>1F4DA9C5-BE74-4894-963A-A9345EE2DF9A</gtr:id><gtr:outcomeId>fmZqVeoMG5h</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://europepmc.org/abstract/MED/21438788</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BHIVA Guidelines (2008 &amp;amp; 2012)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>Guidelines for the management of HIV infection in pregnant women</gtr:guidelineTitle><gtr:id>8C623E04-9494-45E8-8499-C9B6D55831FC</gtr:id><gtr:outcomeId>44C57C75C9C</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://europepmc.org/abstract/MED/18453857</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in Cochrane review</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5BFF9F26-D8D3-47C7-9D89-28C528697576</gtr:id><gtr:outcomeId>UxuZVfB64RZ</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>RCOG Guidelines</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>Management of HIV in Pregnancy (Green-top Guideline No. 39)</gtr:guidelineTitle><gtr:id>160DE96D-6BD2-4850-92BA-8BE8558A3039</gtr:id><gtr:outcomeId>aUNHznyxgDy</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.rcog.org.uk/womens-health/clinical-guidance/management-hiv-pregnancy-green-top-39</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in systematic review of efavirenz in pregnancy</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>DE3F90C9-777C-4DD2-A5D1-30A0E4A66E52</gtr:id><gtr:outcomeId>Ado8fJKvHy5</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO Guideline</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Antiretroviral Drugs For Treating Pregnant Women And Preventing HIV Infection In Infants</gtr:guidelineTitle><gtr:id>3B4C832F-7BDC-4E08-9D3C-38E379C996D0</gtr:id><gtr:outcomeId>dRm9VD2G24M</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.who.int/hiv/pub/mtct/guidelines/en/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BHIVA breastfeeding guidelines</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>British HIV Association and Children's HIV Association position statement on infant feeding in the UK 2011</gtr:guidelineTitle><gtr:id>468C89EC-9913-4414-93C4-6CB5BFEE3C5E</gtr:id><gtr:outcomeId>BGnWwTNQtGn</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D6514CA9-2524-4F26-8A6B-4F9DDFBB81FE</gtr:id><gtr:title>Fertility intentions of HIV-infected women in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>AIDS care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/432b031bc1bc535e3a2009f4ca4007a6"><gtr:id>432b031bc1bc535e3a2009f4ca4007a6</gtr:id><gtr:otherNames>Cliffe S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0954-0121</gtr:issn><gtr:outcomeId>ovfxPaP3RyU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB20959D-4371-4938-BBEC-DAD9157AFBD3</gtr:id><gtr:title>Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fedc2d150b705b855862c0bfca5c005f"><gtr:id>fedc2d150b705b855862c0bfca5c005f</gtr:id><gtr:otherNames>Townsend CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>363996B84CF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF2C4BD6-F8EB-4115-B5A4-00588D64D1FC</gtr:id><gtr:title>Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c7d949cfbba6cacb8bb87e37f843e01"><gtr:id>3c7d949cfbba6cacb8bb87e37f843e01</gtr:id><gtr:otherNames>Tariq S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>DNgcSh5xX2G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92599737-C8A9-4DDD-A138-A858AE656B59</gtr:id><gtr:title>Use of neonatal post-exposure prophylaxis for prevention of mother-to-child HIV transmission in the UK and Ireland, 2001-2008.</gtr:title><gtr:parentPublicationTitle>HIV medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7251e9bdd8fde8e157079174e7ac6b8"><gtr:id>e7251e9bdd8fde8e157079174e7ac6b8</gtr:id><gtr:otherNames>Haile-Selassie H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1464-2662</gtr:issn><gtr:outcomeId>kNC8ACVh4Ho</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ECEEAE2-3509-436F-8F40-5B7F479521F9</gtr:id><gtr:title>Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fedc2d150b705b855862c0bfca5c005f"><gtr:id>fedc2d150b705b855862c0bfca5c005f</gtr:id><gtr:otherNames>Townsend CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>6DD7C2D79A4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EF83B4D-0275-4A21-9F4E-F84E2EB4C9F9</gtr:id><gtr:title>Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbed0d0ed1b4e7a456afc4788aa21d0e"><gtr:id>dbed0d0ed1b4e7a456afc4788aa21d0e</gtr:id><gtr:otherNames>Townsend C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>arfx1Q98sfq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0EC61B1-C2AB-4E5B-958F-B1B276AE9AA1</gtr:id><gtr:title>Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission.</gtr:title><gtr:parentPublicationTitle>Antiviral therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fedc2d150b705b855862c0bfca5c005f"><gtr:id>fedc2d150b705b855862c0bfca5c005f</gtr:id><gtr:otherNames>Townsend CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1359-6535</gtr:issn><gtr:outcomeId>Tj5RauH8AaM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EFD836B-41E6-4114-8CF8-ED770EFB6BD1</gtr:id><gtr:title>Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fedc2d150b705b855862c0bfca5c005f"><gtr:id>fedc2d150b705b855862c0bfca5c005f</gtr:id><gtr:otherNames>Townsend CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>C137E0FC51E</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501895</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>